| GRANT
AGENCY |
GRANT´S
NUMBER |
THE
GRANT´S NAME |
SOLUTION
TIME |
GRANT´S
CO-ORDINATOR |
GROUP |
|
EU – FP6
|
018933 |
Clinigene
European clinical Gene Transfer Advisory Network |
2005-2011 |
J.
Bubeník |
11 |
| GSF |
GA301/07/1410 |
Immunosuppressive
cell populations in the course of
tumour progression and therapy |
2007-2011 |
M.
Reiniš |
11 |
| GSF |
GA301/09/1024 |
Molecular
and cellular mechanisms of tumour chemotherapy: immunomodulatory effects |
2009-2011 |
M.
Indrová |
11 |
| GSF |
GAP301/10/2174 |
Epigenetic
mechanisms in regulativ of genes
important for antigen presentation and antitumour immunity |
2010-2013 |
M.
Reiniš |
11 |
| GSF |
GPP301/11/P220 |
Mechanisms
underlying cyclophosphamide-induced
accumulation of myeloid derived suppressor
cells |
2011-2013 |
R.
Mikyšková |
11 |
| MH CR |
NS10660-3/2009 |
Development
of experimental anti-WT 1 vaccine for
immunotherapy of tumours |
2009-2011 |
M.
Indrová (co-investigator) |
11 |
| EU |
037377 |
Engineering
of the porcine genome for
xenotransplantation studies in primates: a step towards clinical
application |
2006-2011 |
J.
Hejnar |
12 |
| GSF |
GA301/09/P667 |
Transcriptional
silencing of retroviral vectors
during their integration into the host genome |
2009-2011 |
F.
Šenigl |
12 |
| GSF |
GA301/09/2031 |
Fuzogenic envelope glycoproteins of human endogenous
retroviruses and thein receptors |
2009-2011 |
J.
Hejnar |
12 |
| GSF |
GAP502/10/1651 |
Characterization
of new avian sarcoma and leukosis virus (ASLV) receptor alleles as
revealed by
the analysis of semiresistant cells |
2010-2012 |
J.
Plachý |
12 |
| GSF |
GAP502/11/2207 |
Avian
Sarcoma and Leukosis Virus-based Vectors and
Their Potential for Transgenesis in chicken |
2011-2013 |
J.
Hejnar |
12 |
| GA
ASCR |
IAA500520707 |
The
role of innate immune molecules in embryonic
homeostasis and sterile inflammation |
2007-2011 |
D.
Filipp |
13 |
| GSF |
GA310/09/2084 |
Characterization
of the molecular machinery regulating the recruitment of signaling
molecules to
lipid rafts |
2009-2013 |
D.
Filipp |
13 |
| ME CR |
2B08066 |
Novel
treatment of genetically determined metabolic
disease, type 1 diabetes, using an immunotherapeutical approach |
2008-2011 |
D.
Filipp |
13 |
| GA
ASCR |
IAA500390701 |
Role
of proteins associated with Cannabinoid
receptor CB1 in trafficking |
2007-2011 |
J.
Blahoš |
14 |
| GSF |
GA303/08/1591 |
Study
of
glutamate receptors conformational changes using novel fluorescent
techniques |
2008-2012 |
J.
Blahoš |
14 |
| GSF |
GA310/08/1697 |
First
genetic model for analysis of susceptibility
to parasite Leishmania tropica: potential implications for studies of
human
leishmaniases |
2008-2012 |
M.
Lipoldová |
15 |
| GSF |
GAP502/11/2116 |
Rozdíly
v klinickém průběhu klíšťové
encefalitidy u hostitele a jejich genetická determinace |
2011-2015 |
M.
Lipoldová (co-investigator) |
15 |
| ME CR |
LC06009 |
Centre
for molecular ecology of vectors and
pathogens |
2006-2010 |
M.
Lipoldová |
15 |
| ASCR |
KAN200520801 |
Targeted
expression and transport of bioactive
molecules |
2008-2012 |
D.
Staněk |
16 |
| GSF |
GAP305/10/0424 |
Regulation
of alternative splicing via chromatin acetylation |
2010-2013 |
D.
Staněk |
16 |
| GSF |
GAP302/11/1910 |
Formation
of splicing machinery in the context of
the cell nucleus |
2011-2014 |
D.
Staněk |
16 |
|
EU – FP6
|
LSHP-CT-2007-037693 |
HIV
protease inhibitor resistence by
enzyme-substrate coevolution |
2007-2011 |
R.
Sedláček |
18 |
| EU -
FP7 |
HEALTH.2011.1.4-5 |
New
therapeutic approaches in chronic inflammatory
and autoimmune diseases |
Nov2010-2011 |
R.
Sedláček |
18 |
| GA
ASCR |
IAA500520812 |
Investigating
the pathologic role of
metalloproteinases in liver using transgenic mice with conditional
expression
of transgenes |
2008-2012 |
R.
Sedláček |
18 |
| GSF |
GAP305/10/2143 |
Generation
of mouse models for targeting stelete
cells and myofibroblasts in the liver |
2010-2013 |
R.
Sedláček |
18 |
| GSF |
GAP303/10/2044 |
The
Impact of a liver-specific deficiency of growth
factor sheddase ADAM10 on liver development and pathology |
2010-2013 |
R.
Sedláček |
18 |
| GSF |
GAP302/11/2048 |
Function
of metalloproteinases in colon epithelium
and during development of experimental colitis and colon cancer |
2011-2014 |
R.
Sedláček |
18 |
| OPVK |
CZ.1.07/2.3.00/20.0102 |
Founding of an expert team for the Centre for
Phenogenomics |
2011-2014 |
R. Sedláček |
18 |
| ASCR |
KAN200520804 |
Biocompatible
nanofiber scaffolds forming novel
drug matrices for the application of biologically and pharmacologically
active
substances |
2008-2012 |
V. Holáň
|
19 |
| GSF |
GD310/08/H077 |
Regulation
of immunological mechanisms in health
and disease:Development of new diagnostic and therapeutic approaches |
2008-2011 |
V.
Holáň (co-investigator) |
19 |
| GSF |
GA206/08/0640 |
Host-parasite
relationship, hybrid zone, immune systém, house mouse, Mus
musculus |
2008-2012 |
V.
Holáň (co-investigator) |
19 |
| GSF |
GAP304/11/0653 |
Targeted
differentiation and transdifferentiation
of limbal and mesenchymal stem cells and their therapeutic applications
in
preclinical models |
2011-2014 |
V.
Holáň |
19 |
| GSF |
GAP301/11/1568 |
Cellular
aspects of transplantation tolerance |
2011-2014 |
V.
Holáň (co-investigator) |
19 |
| GSF |
GAP305/11/1780 |
Wnt
signaling in self-renewal and tumorigenesis of
the intestinal epithelia |
2011-2014 |
V.
Kořínek |
20 |
| GSF |
GAP304/11/1252 |
Bakterie
v etiologii, prevenci a terapii
experimentálně vyvolaných střevních zánětů
a kolorektálního karcinomu |
2011-2014 |
V.
Kořínek (co-investigator) |
20 |
| ME CR |
2B06077 |
High
throughput analysis of chromatin structure for
development of novel diagnostic and therapeutic approaches in cancer |
2006-2011 |
V.
Kořínek |
20 |
|
ASCR
|
Premium
Academiae |
Premium
Academiae |
2007-2013 |
J.
Forejt |
21 |
| GSF |
GAP305/10/1931 |
Identification
of interactors of the meiotic histone methyltransferase Hybrid
sterility 1
/PR-domain 9) |
2010-2013 |
Z.
Trachtulec |
21 |
| GSF |
GPP305/11/P630 |
Epigenetic
regulators of gene expression in mouse
spermatogenesis |
2011-2013 |
O.
Mihola |
21 |
| ASCR |
M200520901 |
Novel
components of mast cell immune receptor
signalling |
2009-2012 |
Pe.
Dráber |
22 |
| ASCR |
KAN200520701 |
Nano-PCR
- ultrasensitive test for detection of
specific proteins in body fluids |
2007-2011 |
Pe.
Dráber |
22 |
| GSF |
GA301/09/1826 |
Topography
and function of Csk-binding proteins of the plasma membrane in mast
cells |
2009-2013 |
Pe.
Dráber |
22 |
| TA CR |
TA01010436 |
New generations of DNA aptamers |
2011-2013 |
Pe. Dráber |
22 |
| GSF |
GAP302/10/1759 |
Function-structure
relationships between
transmembrane adaptor-based signalosomes in mast cells |
2010-2013 |
L.
Dráberová |
22 |
| MIT |
FR-TI3/067 |
Genetically modified polymerases and their utilization
for amplification of non-purified DNA |
2011-2014 |
Pe. Dráber |
22 |
| ASCR |
KAN200520703 |
The
use of ultrasound in nanomedicine |
2007-2011 |
L.
Anděra (co-investigator) |
23 |
| GSF |
GAP301/10/1971 |
Expression,
signaling and function of Death Receptors in human embryonic stem cells |
2010-2012 |
L.
Anděra |
23 |
| MH CR |
NS10287-3/2009 |
Experimental
therapy of mantle cell lymphoma
(Mantle Cell Lymphoma, MCL) |
2009-2011 |
L.
Anděra (co-investigator) |
23 |
| GSF |
GEMEM/09/E011 |
Signaling
and adaptor
proteins of leukocyte membrane microdomains |
2009-2012 |
V.
Hořejší |
24 |
| GSF |
GAP305/11/0459 |
Vliv
transmembránových domén integrálních
proteinů na dynamickou organizaci
plazmatické membrány T lymfocytů |
2011-2014 |
T.
Brdička (co-investigator) |
24 |
| ME CR |
1M0506 |
Center
of Molecular and Cellular Immunology |
2005-2011 |
V.
Hořejší |
24 |
| ME CR |
2B06064 |
New
target genes for childhood leukemia diagnosis
and treatment focused on adaptor molecules of signaling pathways |
2006-2011 |
T.
Brdička |
24 |
| ASCR |
KAN200520704 |
New
nanoparticles for ultrastructural diagnostics |
2007-2011 |
P. Hozák |
25 |
| GSF |
GD204/09/H084 |
Molecular
biology of a differentiating cell |
2009-2012 |
P.
Hozák |
25 |
| GSF |
GAP305/11/2232 |
Functions
of myosin I and its binding partners in
the cell nucleus |
2011-2015 |
P.
Hozák |
25 |
| MIT |
FR-TI3/588 |
Vývoj
kitu pro detekci mutací strukturních proteinů
buňky |
2011-2015 |
P.
Hozák |
25 |
| ME CR |
ME09101 |
Cooperative
contribution of actin- and myosin-families to the chromatin dynamics
and
tranion in the cell nucleus |
2009-2011 |
P. Hozák |
25 |
| ME CR |
LC545 |
Functional
organisation of the cell |
2005-2011 |
P.
Hozák |
25 |
| ME CR |
2B06063 |
Flurescence
microscopy in biological and medical
research |
2006-2011 |
P. Hozák |
25 |
| ME CR |
LC06063 |
Flurescence
microscopy in biological and medical research |
2006-2011 |
P. Hozák |
25 |
| GSF |
GA204/09/1777 |
Analysis
of signaling assemblies containing
gamma-tubulin |
2009-2011 |
Pa.
Dráber |
26 |
| GSF |
GAP302/10/1701 |
Analysis
of functional differences between
gamma-tubulins |
2010-2012 |
E.
Dráberová |
26 |
| GSF |
GPP302/11/P709 |
Analysis
of microtubular changes during activation
of mast cells |
2011-2013 |
V.
Sulimenko |
26 |
| GSF |
GA204/09/0085 |
RNA
silencing and long dsRNA in mammalian cells |
2009-2013 |
P.
Svoboda |
28 |
| GSF |
GAP305/10/2215 |
Control
of chromatin and pluripotency by microRNAs |
2010-2013 |
P.
Svoboda |
28 |
| ME CR |
ME09039 |
Role
of posttranslational mechanisms in
reprogramming mouse oocytes to pluripotent cells |
2009-2012 |
P.
Svoboda |
28 |
| GA
ASCR |
IAA500520908 |
The
role
of Pax genes in eye evolution |
2009-2013 |
Z.
Kozmik |
29 |
| GSF |
GD204/09/H058 |
Intercellular
signalling in development of the
organism and in disease genesis |
2009-2012 |
Z.
Kozmik (co-investigator) |
29 |
| GSF |
GAP301/11/2198 |
Genetics
of mammalian eye development |
2011-2014 |
Z.
Kozmik |
29 |
| GSF |
GAP305/10/2141 |
Evolution
of photoreceptors: insights from ancestral regulatory circuits |
2010-2014 |
Z.
Kozmik |
29 |
| GSF -
Eurocores |
GCP305/10/J064 |
Reconstructing
urbilaterian photoreceptors: comparative study between Branchiostoma
(Chordata)
and Platynereis (Annelida) |
2010-2012 |
Z.
Kozmik (co-investigator) |
29 |
| GSF |
GA203/09/0820 |
Structurally
inspired synthese of the selectiv inhibitors nukleotidas, potentially
important
medicals |
2009-2013 |
J.
Brynda |
31 |
| MPO |
2A-2TP1/076 |
Generic
therapeutic antibodies |
2007-2011 |
J.
Sedláček |
31 |
| ME CR |
1M0505 |
Center
of
targeted therapeutic drugs |
2005-2011 |
M.
Fábry (co-investigator) |
31 |
| GSF |
GCP305/10/J052 |
Functional
analysis of endogenous retroviral
elements in human genome: possible association with cancers |
2010-2012 |
J.
Pačes |
33 |
| GSF |
GAP305/11/1061 |
Evoluce
parazitismu: analýza genomu a klíčových
fyziologických funkcí volně žijící
améby Mastigamoeba balamuthi a patogena
Entamoeba histolytica |
2011-2015 |
J.
Pačes (co-investigator) |
33 |
| GSF |
GAP506/11/1317 |
Diverzita
a evoluce anaerobních heteroloboseí |
2011-2014 |
Č.
Vlček (co-investigator) |
33 |
| GSF |
GAP506/11/1320 |
Vznik
sekundárního plastidu u euglenidů |
2011-2015 |
Č.
Vlček (co-investigator) |
33 |
| ME CR |
1M0520 |
Center
for Applied Genomics |
2005-2011 |
V.
Pačes |
33 |
| ME CR |
2B06106 |
Novel
genomic and biotechlological approaches in
molecular oncology: a way to the early diagnostics and targeted therapy |
2006-2011 |
Č.
Vlček |
33 |
| ME CR |
2B08031 |
Metagenomics and bioinformatics as a basis for preparation of effective approaches,
preparation and
characterization of microorganisms and their consortia for utilization in bioremediation
|
2008-2011 |
J.
Pačes |
33 |
| GSF |
GA203/09/1311 |
Synthetic
probes for recognition of tumor markers:
applications for cell directed
apoptosis and targeted photodynamic therapy |
2009-2012 |
J.
Králová |
36 |
| GSF |
GA301/09/1727 |
Large-scale
identification of genes responsible for the formation of solid tumours |
2009-2012 |
M.
Dvořák |
36 |
| GSF |
GAP305/10/2133 |
The
study
of satellite cells migration |
2010-2012 |
P.
Kašpar |
36 |
| GSF |
GAP303/11/1291 |
Nové
typy ligandů pro interferenci komunikace
rakovinových buněk jako nová
terapeutická strategie |
2011-2014 |
J.
Králová (co-investigator) |
36 |
| ME CR |
LC06061 |
Center
of Cell Invasiveness in Embryonic
Development and Tumour Metastases |
2006-2011 |
M.
Dvořák |
36 |
| EU -
FP7 |
TRIREME
223575 |
Systems-Level,
Multi-Layer Understanding of Cellular Responses to Ionizing Radiation |
2009-2012 |
J.
Bartek |
37 |
| GSF |
GA204/08/1418 |
The
role of the JAK/STATsignalling pathway in
cellular senescence |
2008-2012 |
Z. Hodný
|
37 |
| GSF |
GPP305/10/P420 |
Role
of Wip1 phosphatase in the DNA damage response |
2010-2012 |
L.
Macůrek |
37 |
| GSF |
GAP301/10/1525 |
Mechanisms
of DNA damage checkpoint termination |
2010-2012 |
J.
Bartek |
37 |
| GSF |
GPP305/11/P683 |
Post-translational
modifications of Daxx and their
functional relevance in DNA
damage response and cellular senescence |
2011-2013 |
H.
Hanzlíková |
37 |
| EU -
FP6 |
018652
CRESCENDO |
Consortium for
Research into Nuclear Receptors in
Development and Aging |
2006-2011 |
P.
Bartůněk |
38 |
| GSF |
GA310/08/0878 |
The
role
of the cells prion protein in erytroidnic differentiation |
2008-2012 |
P.
Bartůněk (co-investigator) |
38 |
| GSF |
GA204/09/1905 |
Disp3:
A
potential role in the self renewal and differentiation of neural stem
cells |
2009-2012 |
P.
Bartůněk |
38 |
| GSF |
GAP305/10/0953 |
New
regulators of megakaryocyte and erythroid lineage commitment |
2010-2013 |
P.
Bartůněk |
38 |
| ME CR |
LC06077 |
Center
of Chemical Genetics |
2006-2010 |
P.
Bartůněk |
38 |
| OPPK |
CZ-OPENSCREEN
CZ.2.16/3.1.00/24020 |
Národní
infrastruktura pro chemickou biologii |
2011- |
P.
Bartůněk |
38 |
| GSF |
GA204/09/0565 |
Role
of RECQ5 DNA helicase in maintenance of
genomic
stability |
2009-2013 |
P.
Janščák |
42 |
| GSF |
GAP305/10/0281 |
Role
of
the Rothmund-Thomson syndrome gene product in maintenance of genomic
stability |
2010-2014 |
P.
Janščák |
42 |
| GSF |
GAP302/11/1481 |
Serine
proteases of human parasite Schistosoma
mansoni and their function in host-parasite interactions |
2011-2014 |
J.
Dvořák |
43 |
| EU FP7 |
PIRG05-GA-2009-248642
|
Schistosoma
Protease |
2009-2013 |
J. Dvořák |
43 |
